These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27730195)

  • 21. Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa.
    Pages-Monteiro L; Marti R; Commun C; Alliot N; Bardel C; Meugnier H; Perouse-de-Montclos M; Reix P; Durieu I; Durupt S; Vandenesch F; Freney J; Cournoyer B; Doleans-Jordheim A
    PLoS One; 2017; 12(3):e0173022. PubMed ID: 28282386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is genotyping of single isolates sufficient for population structure analysis of Pseudomonas aeruginosa in cystic fibrosis airways?
    Sommer LM; Marvig RL; Luján A; Koza A; Pressler T; Molin S; Johansen HK
    BMC Genomics; 2016 Aug; 17():589. PubMed ID: 27506816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parallel Analysis of Cystic Fibrosis Sputum and Saliva Reveals Overlapping Communities and an Opportunity for Sample Decontamination.
    Lu J; Carmody LA; Opron K; Simon RH; Kalikin LM; Caverly LJ; LiPuma JJ
    mSystems; 2020 Jul; 5(4):. PubMed ID: 32636336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional profiling and genetic analysis of a cystic fibrosis airway-relevant model shows asymmetric responses to growth in a polymicrobial community.
    Kesthely CA; Rogers RR; El Hafi B; Jean-Pierre F; O'Toole GA
    Microbiol Spectr; 2023 Sep; 11(5):e0220123. PubMed ID: 37772884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in the lung bacteriome in relation to antipseudomonal therapy in children with cystic fibrosis.
    Kramná L; Dřevínek P; Lin J; Kulich M; Cinek O
    Folia Microbiol (Praha); 2018 Mar; 63(2):237-248. PubMed ID: 29127619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis.
    Mainz JG; Naehrlich L; Schien M; Käding M; Schiller I; Mayr S; Schneider G; Wiedemann B; Wiehlmann L; Cramer N; Pfister W; Kahl BC; Beck JF; Tümmler B
    Thorax; 2009 Jun; 64(6):535-40. PubMed ID: 19282318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosis.
    Willger SD; Grim SL; Dolben EL; Shipunova A; Hampton TH; Morrison HG; Filkins LM; O'Toole GA; Moulton LA; Ashare A; Sogin ML; Hogan DA
    Microbiome; 2014; 2():40. PubMed ID: 25408892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.
    Greipel L; Fischer S; Klockgether J; Dorda M; Mielke S; Wiehlmann L; Cramer N; Tümmler B
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6726-6734. PubMed ID: 27572404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystic fibrosis sputum supports growth and cues key aspects of Pseudomonas aeruginosa physiology.
    Palmer KL; Mashburn LM; Singh PK; Whiteley M
    J Bacteriol; 2005 Aug; 187(15):5267-77. PubMed ID: 16030221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Continuous-Flow Model for
    O'Brien TJ; Welch M
    Front Microbiol; 2019; 10():2713. PubMed ID: 31824471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ecological Succession of Polymicrobial Communities in the Cystic Fibrosis Airways.
    Khanolkar RA; Clark ST; Wang PW; Hwang DM; Yau YCW; Waters VJ; Guttman DS
    mSystems; 2020 Dec; 5(6):. PubMed ID: 33262240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of behaviour and virulence of a high alginate expressing Pseudomonas aeruginosa strain from cystic fibrosis by oral commensal bacterium Streptococcus anginosus.
    Waite RD; Qureshi MR; Whiley RA
    PLoS One; 2017; 12(3):e0173741. PubMed ID: 28301571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cystic fibrosis lung microbiome.
    Surette MG
    Ann Am Thorac Soc; 2014 Jan; 11 Suppl 1():S61-5. PubMed ID: 24437409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcriptional Profiling and Genetic Analysis of a Cystic Fibrosis Airway-Relevant Model Shows Asymmetric Responses to Growth in a Polymicrobial Community.
    Kesthely CA; Rogers RR; Hafi BE; Jean-Pierre F; O'Toole GA
    bioRxiv; 2023 May; ():. PubMed ID: 37293107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interspecies Metabolic Complementation in Cystic Fibrosis Pathogens via Purine Exchange.
    Al Mahmud H; Baishya J; Wakeman CA
    Pathogens; 2021 Feb; 10(2):. PubMed ID: 33535659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
    Aanæs K
    J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The microbial community of the cystic fibrosis airway is disrupted in early life.
    Renwick J; McNally P; John B; DeSantis T; Linnane B; Murphy P;
    PLoS One; 2014; 9(12):e109798. PubMed ID: 25526264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways.
    Trend S; Fonceca AM; Ditcham WG; Kicic A; Cf A
    J Cyst Fibros; 2017 Nov; 16(6):663-670. PubMed ID: 28720345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temperate Bacteriophages from Chronic Pseudomonas aeruginosa Lung Infections Show Disease-Specific Changes in Host Range and Modulate Antimicrobial Susceptibility.
    Tariq MA; Everest FLC; Cowley LA; Wright R; Holt GS; Ingram H; Duignan LAM; Nelson A; Lanyon CV; Perry A; Perry JD; Bourke S; Brockhurst MA; Bridge SH; De Soyza A; Smith DL
    mSystems; 2019 Jun; 4(4):. PubMed ID: 31164451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.